Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Valeant Pharmaceuticals International Inc. (T.BHC) had Free Cash Flow per Share of 0.37 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-83.29M |
|
-- |
|
-- |
|
-- |
|
396.36M |
|
-- |
|
-67.50M |
|
-67.50M |
|
-123.50M |
|
-123.50M |
|
-123.50M |
|
-123.50M |
|
396.36M |
|
855.92M |
|
369.60M |
|
369.60M |
|
-0.23 |
|
-0.23 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
37.94B |
|
-- |
|
-- |
|
-- |
|
38.29B |
|
-344.66M |
|
-23.97B |
|
-344.66M |
|
369.54M |
|
| Cash Flow Statement Financials | |
303.02M |
|
-186.69M |
|
-209.67M |
|
1.72B |
|
1.66B |
|
-63.19M |
|
61.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
-- |
|
-1.18 |
|
68.97% |
|
12.22% |
|
12.22% |
|
-- |
|
-2.08% |
|
-2.57% |
|
137.87M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.43 |
|
1.09 |
|
82.55 |
|
35.83% |
|
0.52% |
|
-0.33% |
|
35.83% |
|
-0.93 |
|
|
Free Cash Flow per Share |
0.37 |
0.82 |
|